(Q35177431)

6 August 2017

1 reference

title

Links between rhinitis and asthma (English)

1 reference

6 August 2017

1 reference

Bousquet J

1

1 reference

PubMed ID

12859545

6 August 2017

Vignola AM

series ordinal

2

1 reference

PubMed ID

12859545

6 August 2017

Demoly P

series ordinal

3

1 reference

6 August 2017

1 August 2003

1 reference

6 August 2017

1 reference

6 August 2017

58

1 reference

6 August 2017

8

1 reference

6 August 2017

691-706

1 reference

Secular trends of allergic asthma in Danish adults. The Copenhagen Allergy Study.

6 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Asthma, rhinitis, and skin test reactivity to aeroallergens in families of asthmatic subjects in Anqing, China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Is bronchial hyperresponsiveness more frequent in women than in men? A population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Is allergen exposure the major primary cause of asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Bakery work, atopy and the incidence of self-reported hay fever and rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Asthma and rhinitis due to ethylcyanoacrylate instant glue

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Medical surveillance of allergy in laboratory animal handlers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Occupational asthma caused by triglycidyl isocyanurate (TGIC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Occupational asthma caused by exposure to cyanoacrylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Pulmonary inflammation after segmental ragweed challenge in allergic asthmatic and nonasthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Asthma associated with thunderstorms

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Thunderstorm associated asthma: a detailed analysis of environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Thunderstorm outflows preceding epidemics of asthma during spring and summer

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Mechanism of grass-pollen-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Thunderstorm-associated asthma in an inland town in south-eastern Australia. Who is at risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

The role of viral infections in the natural history of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

The mechanics of exaggerated airway narrowing in asthma: the role of smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Asthma. From bronchoconstriction to airways inflammation and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

21 January 2018

The human IgE network

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

The role of IgE in allergen-induced inflammation and the potential for intervention with a humanized monoclonal anti-IgE antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Unique mechanistic features of allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Increased expression of high affinity IgE (FcepsilonRI) receptor-alpha chain mRNA and protein-bearing eosinophils in human allergen-induced atopic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Persistent IgE synthesis in the nasal mucosa of hay fever patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Increases in allergen-specific IgE in BAL after segmental allergen challenge in atopic asthmatics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Systemic aspects of allergic disease: bone marrow responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Development of seasonal allergic rhinitis during the first 7 years of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Development of allergies and asthma in infants and young children with atopic dermatitis--a prospective follow-up to 7 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Rhinitis as an independent risk factor for adult-onset asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Airway smooth muscle cells: contributing to and regulating airway mucosal inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Epithelial-mesenchymal interactions in the pathogenesis of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Quality of life in allergic rhinitis and asthma. A population-based study of young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

The work impact of asthma and rhinitis: findings from a population-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Allergic rhinitis and its impact on asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Different effects of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Effects of orally inhaled budesonide in seasonal allergic rhinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Intranasal steroids and the risk of emergency department visits for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Rhinitis caused by ninhydrin develops into occupational asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Local expression of ϵ germline gene transcripts and RNA for the ϵ heavy chain of IgE in the bronchial mucosa in atopic and nonatopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

Relationships between rhinitis and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Allergic rhinobronchitis: the asthma-allergic rhinitis link

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

American Thoracic Society Workshop. Immunobiology of asthma and rhinitis. Pathogenic factors and therapeutic options

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Rhinitis and asthma: a continuum of disease?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects☆☆☆★Results from the European Community Respiratory Health Survey

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Allergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on health care charges.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Quality-of-life outcomes and the use of antihistamines in a French national population-based sample of patients with perennial rhinitis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Differences in nonspecific bronchial responsiveness between patients with asthma and patients with rhinitis are not explained by type and degree of inhalant allergy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Aspirin-induced asthma: advances in pathogenesis and management

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

House dust mite allergens. A major risk factor for childhood asthma in Australia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Importance of house dust mite and Alternaria allergens in childhood asthma: an epidemiological study in two climatic regions of Australia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Is sensitization to Alternaria alternata a risk factor for severe asthma? A population-based study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and Nutrition Examination Survey, 1976-80 (NHANES II)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Seasonal allergic symptoms and their relation to pollen exposure in south-east France

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Prevalence of self-reported respiratory symptoms in workers exposed to isocyanates

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Prevalence and intensity of rhinoconjunctivitis in subjects with occupational asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Baker's asthma: causes and prevention

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

A respiratory epidemiologic survey of grain mill workers in Cape Town, South Africa.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Nasal hypersensitivity in wood furniture workers. An allergological and immunological investigation with special reference to mould and wood

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Occupational allergic rhinitis in Finland

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Asthma and rhinitis after exposure to glutaraldehyde in endoscopy units.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Occupational asthma in an electronics factory

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Asthma and rhinitis related to laboratory rats: use of a purified rat urinary allergen to study exposure in laboratories and the human immune response

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Latex-specific proteins causing immediate-type cutaneous, nasal, bronchial, and systemic reactions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Natural rubber latex allergy after 12 years: recommendations and perspectives

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Occupational skin and respiratory diseases among hairdressers

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

1 reference

7 January 2021

Asthma and rhinitis induced by exposure to raw green beans and chards

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Nasal and bronchial responses to flour-inhalation in subjects with occupationally induced allergy affecting the airway

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

A review of current literature on epidemiology of immediate glove irritation and latex allergy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Latex symptoms and sensitisation in health care workers

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Occupational asthma, rhinitis and urticaria due to piperacillin sodium in a pharmaceutical worker

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Cytokine expression in the lower airways of nonasthmatic subjects with allergic rhinitis: influence of natural allergen exposure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Increased airway inflammation with segmental versus aerosol antigen challenge

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Enhanced Superoxide Production by Alveolar Macrophages and Air-Space Cells, Airway Inflammation, and Alveolar Macrophage Density Changes after Segmental Antigen Bronchoprovocation in Allergic Subjects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Asthma outbreak during a thunderstorm

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Grass pollen, thunderstorms and asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Viruses and asthma exacerbations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Rhinoviruses infect the lower airways

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Detection of rhinovirus RNA in lower airway cells during experimentally induced infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Quantitation of inflammatory cells in the nasal mucosa of patients with allergic rhinitis and normal subjects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Bronchial biopsies and airway inflammation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Phenol amplifies complement-fixing activity and induces IgG-precipitating activity in grain-dust extract

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Pathogenesis of allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Comparison between nasal and bronchial inflammation in asthmatic and control subjects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

1 reference

7 January 2021

Metered-dose inhalers: mouth open or closed?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Rhinosinusitis in severe asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Chronic sinusitis in severe asthma is related to sputum eosinophilia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Total serum IgE and its association with asthma symptoms and allergic sensitization among children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Elevation of total serum immunoglobulin E is associated with asthma in nonallergic individuals

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Enhanced expression of high-affinity IgE receptor (Fc epsilon RI) alpha chain in human allergen-induced rhinitis with co-localization to mast cells, macrophages, eosinophils, and dendritic cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Molecular concepts of IgE-initiated inflammation in atopic and nonatopic asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Expression of ɛ germ-line gene transcripts and mRNA for the ɛ heavy chain of IgE in nasal B cells and the effects of topical corticosteroid

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Local IgE synthesis in allergic rhinitis and asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Local synthesis of epsilon germline gene transcripts, IL-4, and IL-13 in allergic nasal mucosa after ex vivo allergen exposure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Bone marrow events in animal models of allergic inflammation and hyperresponsiveness

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Rapid increase in bone-marrow eosinophil production and responses to eosinopoietic interleukins triggered by intranasal allergen challenge

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Allergen-induced increase in airway responsiveness, airway eosinophilia, and bone-marrow eosinophil progenitors in mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Increase in IL-8, IL-10, IL-13, and RANTES mRNA levels (in situ hybridization) in the nasal mucosa after nasal allergen provocation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Cellular infiltration and cytokine mRNA expression in perennial allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Distribution of rantes and interleukin-5 in allergic nasal mucosa and nasal polyps

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

IL-5 synthesis is upregulated in human nasal polyp tissue

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Evidence for local eosinophil differentiation within allergic nasal mucosa: inhibition with soluble IL-5 receptor

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

CD34(+)/interleukin-5Ralpha messenger RNA+ cells in the bronchial mucosa in asthma: potential airway eosinophil progenitors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Natural course of sensitization to food and inhalant allergens during the first 6 years of life.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Atopic dermatitis in early infancy predicts allergic airway disease at 5 years

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Longitudinal changes in atopy during a 4-year period: relation to bronchial hyperresponsiveness and respiratory symptoms in a population sample of Australian schoolchildren

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

A clinical index to define risk of asthma in young children with recurrent wheezing

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Nasal inhalation of the glucocorticoid budesonide from a spacer for the treatment of patients with pollen rhinitis and asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Effects of antihistamines in adult asthma: a meta-analysis of clinical trials

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Is there a role for immunotherapy in the treatment of asthma? Yes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Is there a role for immunotherapy in the treatment of asthma? No

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Specific immunotherapy in rhinitis and asthma.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Immunologic changes associated with allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00105.X

7 January 2021

10.1034/J.1398-9995.2003.00105.X

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12859545